Literature DB >> 3171477

Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.

R L Griffith1, G T Virella, H C Stevenson, M F Lopes-Virella.   

Abstract

Human macrophages play a key role in atherogenesis and are believed to be the progenitors of the cholesteryl ester (CE)-laden foam cells present in early atherosclerotic lesions. Several mechanisms by which macrophages accumulate CE have been recently described. One involves a perturbation in LDL metabolism subsequent to macrophage activation. Thus, we decided to study the effect of macrophage activation by immune complexes on N-LDL metabolism. Initially, LDL-containing immune complexes (LDL-IC) were chosen, since increased plasma levels of these IC have been reported in patients with coronary heart disease. Human macrophages stimulated for 22 h with LDL-IC (250 micrograms/ml) and incubated afterwards for 20 h with 10 micrograms/ml 125I-N-LDL showed a six- and fourfold increase in the accumulation and degradation, respectively, of 125I-N-LDL over the values observed in nonstimulated cells. Scatchard analysis of 125I-N-LDL-specific binding suggests an increase (20-fold) in the number of LDL receptors in macrophages stimulated with LDL-IC. We studied other immune complexes varying in size and antigen composition. Some of the IC were able to stimulate, although to a lesser degree, the uptake of N-LDL by macrophages. Lipoprotein IC are more efficient and have the greatest capacity to increase N-LDL uptake and CE accumulation. We conclude that human macrophage activation by LDL-IC leads to an increase in LDL receptor activity and promotes in vitro foam cell formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171477      PMCID: PMC2189038          DOI: 10.1084/jem.168.3.1041

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  60 in total

Review 1.  Secretory products of macrophages and their physiological functions.

Authors:  R Takemura; Z Werb
Journal:  Am J Physiol       Date:  1984-01

2.  Lymphokines secreted by an established lymphocyte line modulate receptor-mediated endocytosis in macrophages derived from human monocytes.

Authors:  A M Fogelman; J Seager; J E Groopman; J A Berliner; M E Haberland; P A Edwards; D W Golde
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

3.  Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control.

Authors:  M F Lopes-Virella; G K Sherer; A M Lees; H Wohltmann; R Mayfield; J Sagel; E C LeRoy; J A Colwell
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

4.  Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages.

Authors:  R J Bonney; J L Humes
Journal:  J Leukoc Biol       Date:  1984-01       Impact factor: 4.962

5.  In vitro and in vivo stimulation of rat neutrophils and alveolar macrophages by immune complexes. Production of O-2 and H2O2.

Authors:  P A Ward; R E Duque; M C Sulavik; K J Johnson
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

6.  Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.

Authors:  J Le; W Prensky; Y K Yip; Z Chang; T Hoffman; H C Stevenson; I Balazs; J R Sadlik; J Vilcek
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

7.  Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

Authors:  J L Witztum; U P Steinbrecher; Y A Kesaniemi; M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 8.  Endocytosis by the mononuclear phagocyte system and autoimmune disease.

Authors:  R P Kimberly; P Ralph
Journal:  Am J Med       Date:  1983-03       Impact factor: 4.965

9.  Characterization of biological response modifier release by human monocytes cultured in suspension in serum-free medium.

Authors:  H C Stevenson; E Schlick; R Griffith; M A Chirigos; R Brown; J Conlon; D J Kanapa; R K Oldham; P Miller
Journal:  J Immunol Methods       Date:  1984-05-25       Impact factor: 2.303

10.  In vitro differentiation of human monocytes. Monocytes cultured on glass are cytotoxic to tumor cells but monocytes cultured on collagen are not.

Authors:  G Kaplan
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  36 in total

1.  Inhibition of foam cell formation using a soluble CD68-Fc fusion protein.

Authors:  Karin Daub; Dorothea Siegel-Axel; Tanja Schönberger; Christoph Leder; Peter Seizer; Karin Müller; Martin Schaller; Sandra Penz; Dagmar Menzel; Berthold Büchele; Andreas Bültmann; Götz Münch; Stephan Lindemann; Thomas Simmet; Meinrad Gawaz
Journal:  J Mol Med (Berl)       Date:  2010-05-08       Impact factor: 4.599

Review 2.  Lipoprotein autoantibodies: measurement and significance.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

3.  Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy.

Authors:  Yoshiro Miyahara; Shinsuke Nishimura; Maho Watanabe; Kenji Ito; Hitoshi Nakashima; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

4.  Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages.

Authors:  Kent J Smith; Waleed O Twal; Farzan Soodavar; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

5.  You are right too!

Authors:  Joseph L Witztum
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

6.  Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.

Authors:  Gabriel Virella; Rickey E Carter; Antonio Saad; Edward G Crosswell; B Andrew Game; Maria F Lopes-Virella
Journal:  Clin Immunol       Date:  2008-06       Impact factor: 3.969

7.  Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.

Authors:  Samar M Hammad; Waleed O Twal; Jeremy L Barth; Kent J Smith; Antonio F Saad; Gabriel Virella; W Scott Argraves; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-05-28       Impact factor: 5.162

8.  Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury.

Authors:  L Prat; G Torres; I Carrió; M Roca; V Riambau; L Berná; M Estorch; I Ferrer; C García
Journal:  Eur J Nucl Med       Date:  1993-12

9.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.

Authors:  Kathryn J Moore; Vidya V Kunjathoor; Stephanie L Koehn; Jennifer J Manning; Anita A Tseng; Jessica M Silver; Mary McKee; Mason W Freeman
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

10.  Detection of Circulating Auto-Antibodies Against Ribosylated-LDL in Diabetes Patients.

Authors:  Firoz Akhter; M Salman Khan; Mohammad Faisal; Abdulrahman A Alatar; Saheem Ahmad
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.